RHUMBLINE ADVISERS - VIR BIOTECHNOLOGY INC ownership

VIR BIOTECHNOLOGY INC's ticker is VIR and the CUSIP is 92764N102. A total of 166 filers reported holding VIR BIOTECHNOLOGY INC in Q2 2021. The put-call ratio across all filers is 0.78 and the average weighting 0.3%.

Quarter-by-quarter ownership
RHUMBLINE ADVISERS ownership history of VIR BIOTECHNOLOGY INC
ValueSharesWeighting
Q3 2023$2,454,792
-59.6%
261,987
+5.8%
0.00%
-57.1%
Q2 2023$6,073,946
+110799.1%
247,613
+5.2%
0.01%0.0%
Q1 2023$5,477
-2.0%
235,388
+6.6%
0.01%
-12.5%
Q4 2022$5,586
-99.9%
220,722
-0.7%
0.01%
+33.3%
Q3 2022$4,287,000
-21.6%
222,367
+3.5%
0.01%
-25.0%
Q2 2022$5,471,000
+228.4%
214,806
+231.6%
0.01%
+300.0%
Q1 2022$1,666,000
-37.7%
64,769
+1.4%
0.00%
-33.3%
Q4 2021$2,674,000
-4.5%
63,854
-0.7%
0.00%
-25.0%
Q3 2021$2,800,000
-5.9%
64,334
+2.2%
0.00%0.0%
Q2 2021$2,976,000
-3.9%
62,951
+4.2%
0.00%0.0%
Q1 2021$3,096,000
+76.7%
60,385
-7.7%
0.00%
+100.0%
Q4 2020$1,752,000
-16.5%
65,435
+7.0%
0.00%
-33.3%
Q3 2020$2,099,000
-25.5%
61,128
-11.2%
0.00%
-40.0%
Q2 2020$2,819,000
+678.7%
68,807
+552.0%
0.01%
+400.0%
Q1 2020$362,00010,5540.00%
Other shareholders
VIR BIOTECHNOLOGY INC shareholders Q2 2021
NameSharesValueWeighting ↓
Bill & Melinda Gates Foundation 1,559,142$30,100,00023.79%
SB INVESTMENT ADVISERS (UK) LTD 22,086,280$425,823,0003.26%
Zebra Capital Management LLC 40,104$773,0002.94%
UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO 130,409$2,514,0000.94%
CLARK ESTATES INC/NY 180,000$3,470,0000.77%
Temasek Holdings (Private) Ltd 6,036,821$116,389,9090.70%
SECTOR GAMMA AS 89,808$1,731,0000.45%
Capital Impact Advisors, LLC 13,196$360,0000.36%
SummerHaven Investment Management, LLC 24,927$481,0000.33%
DUALITY ADVISERS, LP 92,712$1,787,0000.20%
View complete list of VIR BIOTECHNOLOGY INC shareholders